documents: FDA-2014-D-1891-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-D-1891-0002 | FDA | FDA-2014-D-1891 | Draft Guidance for Industry on How to Obtain a Letter from FDA Stating that Bioequivalence Study Protocols Contain Safety Protections Comparable to Applicable REMS for RLD | Other | Guidance | 2014-12-05T05:00:00Z | 2014 | 12 | 2014-12-05T05:00:00Z | 2024-11-11T20:55:08Z | 1 | 0 | 090000648195ee4c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref